| Optimum Health Suwanee Llc | |
|
3131 Lawrenceville Suwanee Rd # B, Suwanee, GA 30024-6548 | |
| (678) 546-0550 | |
| (678) 546-6885 |
| Full Name | Optimum Health Suwanee Llc |
|---|---|
| Type | Facility |
| Speciality | General Practice |
| Location | 3131 Lawrenceville Suwanee Rd # B, Suwanee, Georgia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134532559 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | (* (Not Available)) | Secondary |
| 208D00000X | General Practice | (* (Not Available)) | Primary |
| 225100000X | Physical Therapist | (* (Not Available)) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Optimum Health Suwanee Llc 2133 Highway 317 Ste 12-318, Suwanee, GA 30024-2649 Ph: (678) 546-0550 | Optimum Health Suwanee Llc 3131 Lawrenceville Suwanee Rd # B, Suwanee, GA 30024-6548 Ph: (678) 546-0550 |
News Archive
"Medicare physician payment comes down to the wire today as the Senate scrambles once again to delay the 21 percent Medicare cut before physicians feel the impact in their payments this week and a Medicare meltdown begins. Congress' failure to stave off the Medicare physician payment cut leaves physicians in limbo and puts seniors' access to care and choice of physician in serious jeopardy. This continued uncertainty coupled with the fact that Medicare payments, even without the 21 percent cut, have not kept up with the cost of providing care to seniors demonstrates the need for a permanent solution to this annual problem.
Santarus, Inc., a specialty biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved the company's New Drug Application (NDA) for immediate-release omeprazole/sodium bicarbonate/ magnesium hydroxide tablets in 40 mg and 20 mg dosage strengths of omeprazole.
The board directing the troubled Oregon health exchange is meeting this week to begin making recommendations about next steps and the future. In addition, Washington's health benefit exchange faces challenges of its own.
Every country has been affected by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that has spawned a pandemic. For several factors, the United States has been hit hard by the number of coronavirus cases and death. The country currently leads the world with over 32.4 million infections and more than 577,000 COVID-19 deaths.
Insilico Medicine is pleased to announce that it has entered into a collaboration with Teva Branded Pharmaceutical Products R&D, Inc. to utilize Insilico's generative machine learning technology and proprietary PandaOmics Drug Discovery Platform, which aims at identifying novel therapeutic targets implicated in a variety of diseases.
› Verified 6 days ago